These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 33143077)

  • 21. Risk factors for urinary tract infections due to ciprofloxacin-resistant Escherichia coli in a tertiary care urology department in Switzerland.
    Nicoletti J; Kuster SP; Sulser T; Zbinden R; Ruef C; Ledergerber B; Weber R
    Swiss Med Wkly; 2010; 140():w13059. PubMed ID: 20648400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [National S3 guideline on uncomplicated urinary tract infection: recommendations for treatment and management of uncomplicated community-acquired bacterial urinary tract infections in adult patients].
    Wagenlehner FM; Schmiemann G; Hoyme U; Fünfstück R; Hummers-Pradier E; Kaase M; Kniehl E; Selbach I; Sester U; Vahlensieck W; Watermann D; Naber KG
    Urologe A; 2011 Feb; 50(2):153-69. PubMed ID: 21312083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Summary of European Association of Urology (EAU) Guidelines on Neuro-Urology.
    Groen J; Pannek J; Castro Diaz D; Del Popolo G; Gross T; Hamid R; Karsenty G; Kessler TM; Schneider M; 't Hoen L; Blok B
    Eur Urol; 2016 Feb; 69(2):324-33. PubMed ID: 26304502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of benign prostatic hyperplasia in geriatric patients-use and limitations of existing guidelines].
    Schoeb DS; Wullich B; Dürschmied D; Heimbach B; Heupel-Reuter M; Gross AJ; Wilhelm K; Gratzke C; Miernik A
    Urologe A; 2019 Sep; 58(9):1029-1038. PubMed ID: 31451881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The changing pattern of antimicrobial resistance within 42,033 Escherichia coli isolates from nosocomial, community and urology patient-specific urinary tract infections, Dublin, 1999-2009.
    Cullen IM; Manecksha RP; McCullagh E; Ahmad S; O'Kelly F; Flynn RJ; McDermott T; Murphy P; Grainger R; Fennell JP; Thornhill JA
    BJU Int; 2012 Apr; 109(8):1198-206. PubMed ID: 21883861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of tadalafil 5 mg once daily in the treatment of men with lower urinary tract symptoms suggestive to benign prostatic hyperplasia with or without erectile dysfunction: results from naturalistic observational TadaLutsEd study.
    Bechara A; Casabe A; Rodriguez Baigorri G; Cobreros C
    J Sex Med; 2014 Feb; 11(2):498-505. PubMed ID: 24224728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis and management of male urinary tract infections: a need for new guidelines. Study from a French general practice electronic database.
    Soudais B; Lacroix-Hugues V; Meunier F; Gillibert A; Darmon D; Schuers M
    Fam Pract; 2021 Jul; 38(4):432-440. PubMed ID: 33340317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia.
    Hwang EC; Gandhi S; Jung JH; Imamura M; Kim MH; Pang R; Dahm P
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD007360. PubMed ID: 30306544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Portable bladder ultrasound: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(11):1-51. PubMed ID: 23074481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibiotic Prescribing Patterns and Guideline Concordance for Uncomplicated Urinary Tract Infections Among Adult Women in the US Military Health System.
    Kikuchi JY; Banaag A; Koehlmoos TP
    JAMA Netw Open; 2022 Aug; 5(8):e2225730. PubMed ID: 35925603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EFFICIENCY OF SILDANEFIL MONOTHERAPY IN BENIGN PROSTATIC HYPERPLASIA.
    Grbic D; Vojinov S; Jeremic D; Levakov I; Dozic S; Sekulic V
    Med Pregl; 2016 Nov; 69(11-12):379-383. PubMed ID: 29693865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of the treatment recommendations for neurogenic lower urinary tract dysfunction in the national institute for health and care excellence, European Association of Urology and international consultations on incontinence guidelines.
    Jaggi A; Drake M; Siddiqui E; Fatoye F
    Neurourol Urodyn; 2018 Sep; 37(7):2273-2280. PubMed ID: 29664124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Contemporary Evaluation of Urological Outcomes After Renal Transplantation.
    Kennedy A; Rice MK; Waguespack M; Xie WY; Al-Qaoud T; Malik RD
    Urol Pract; 2023 Jan; 10(1):75-81. PubMed ID: 37103439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Real-world assessment and characteristics of men with benign prostatic hyperplasia (BPH) in primary care and urology clinics in Spain.
    María Molero J; Miñana B; Palacios-Moreno JM; Téllez Martínez-Fornes M; Lorite Mingot D; Agra Rolán A; Carreño Á; Cuervo Pinto R
    Int J Clin Pract; 2020 Nov; 74(11):e13602. PubMed ID: 32609933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What Are the Short-term Benefits and Potential Harms of Therapeutic Modalities for the Management of Overactive Bladder Syndrome in Women? A Review of Evidence Under the Auspices of the European Association of Urology, Female Non-neurogenic Lower Urinary Tract Symptoms Guidelines Panel.
    Farag F; Sakalis VI; Arteaga SM; Sihra N; Karavitakis M; Arlandis S; Bø K; Cobussen-Boekhorst H; Costantini E; de Heide M; Groen J; Peyronnet B; Phé V; van Poelgeest-Pomfret ML; van den Bos TWL; van der Vaart H; Harding CK; Carmela Lapitan M; Imran Omar M; Nambiar AK
    Eur Urol; 2023 Sep; 84(3):302-312. PubMed ID: 37331921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Forecasting the Future of Urology Practice: A Comprehensive Review of the Recommendations by International and European Associations on Priority Procedures During the COVID-19 Pandemic.
    Amparore D; Campi R; Checcucci E; Sessa F; Pecoraro A; Minervini A; Fiori C; Ficarra V; Novara G; Serni S; Porpiglia F
    Eur Urol Focus; 2020 Sep; 6(5):1032-1048. PubMed ID: 32553544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.
    Li MK; Garcia L; Patron N; Moh LC; Sundram M; Leungwattanakij S; Pripatnanont C; Cheng C; Chi-Wai M; Loi-Cheong N
    BJU Int; 2008 Jan; 101(2):197-202. PubMed ID: 18005205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
    Jung JH; Reddy B; McCutcheon KA; Borofsky M; Narayan V; Kim MH; Dahm P
    Cochrane Database Syst Rev; 2019 May; 5(5):CD012832. PubMed ID: 31128077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sonographic assessment of the effect of vesicoureteral reflux and urinary tract infections on growth of the pediatric solitary kidney.
    Ross I; Ahn HJ; Roelof B; Barber T; Huynh V; Rockette A; Popovic M; Chen JJ; Steinhardt G
    J Pediatr Urol; 2015 Jun; 11(3):145.e1-6. PubMed ID: 25864614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Content Analysis of Mobile Phone Applications for the Diagnosis, Treatment, and Prevention of Urinary Tract Infections, and Their Compliance with European Association of Urology Guidelines on Urological Infections.
    Vaggers S; Puri P; Wagenlehner F; Somani BK
    Eur Urol Focus; 2021 Jan; 7(1):198-204. PubMed ID: 32088140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.